Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia

Published:2018-04-28 Issue:7 Volume:93 Page:851-858
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Cao Jiang¹,Wang Gang²,Cheng Hai¹,Wei Chen¹,Qi Kunming¹,Sang Wei¹,Zhenyu Li¹,Shi Ming²,Li Huizhong²,Qiao Jianlin³,Pan Bin³,Zhao Jing¹,Wu Qingyun³,Zeng Lingyu³,Niu Mingshan³^ORCID,Jing Guangjun⁴,Zheng Junnian²⁵⁶,Xu Kailin¹³^ORCID

Affiliation:

1. Department of Hematology; The Affiliated Hospital of Xuzhou Medical University; Xuzhou 221002 China

2. Cancer Institute, Xuzhou Medical University; Xuzhou 221002 China

3. Jiangsu Bone Marrow Stem Cell Institute; Xuzhou 221002 China

4. iCARTAB biomedical co. LTD; Suzhou 215000 China

5. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University; Xuzhou 221002 China

6. Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University; Xuzhou 221002 China

Funder

National Natural Science Foundation of China

Jiangsu Province Social Development Key Projects

China Postdoctoral Science Foundation funded project

Jiangsu Provincial Key Medical Discipline (Laboratory)